An Open-Label Prospective Observational Study of Antiandrogen and Non-Antiandrogen Early Pharmacological Approaches in Females with Mild-to-Moderate COVID-19: The Pre-AndroCoV Female Trial

    October 2020 in “ medRxiv (Cold Spring Harbor Laboratory) ”
    Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier, J. Philip McCoy
    Image of study
    TLDR Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.
    The study from October 2020 involved 270 females with early-stage COVID-19, divided into non-hyperandrogenic (HA) (195 participants), HA (67 participants), and HA using spironolactone (HA-spiro) (8 participants) groups. The study aimed to evaluate the effects of early pharmacological treatment and investigate if HA is an additional risk factor. The treatment included azithromycin, hydroxychloroquine, nitazoxanide, ivermectin, and optionally spironolactone. The results showed that time-to-treat, positive rtPCR, and duration of symptoms were significantly lower in the HA-spiro group than in the non-HA, HA, and overall non-users. HA females presented more severe and prolonged clinical manifestations, but none progressed to worse outcomes. Spironolactone users were more likely to be asymptomatic during COVID-19. The study concluded that early detection and pharmaceutical treatment of COVID-19 showed significant improvements in clinical outcomes, and spironolactone mitigated the additional risks due to HA.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 416 results

      community 5mg oral minoxidil + 100mg Spironolactone

      in Progress Pictures  11 upvotes 1 year ago
      A user shared progress pictures using 5mg oral minoxidil and 100mg spironolactone, noting increased body hair and faster nail growth. Another user humorously suggested a new sub for people with similar experiences.

      community Spironolactone and pregnancy planning

      in Female  2 upvotes 1 month ago
      A user with AGA uses topical spironolactone 2% due to side effects from the oral form and is concerned about its use during conception and breastfeeding. They seek alternatives to prevent AGA relapse while planning pregnancy and after childbirth.

      community spironolactone pills to topical

      in Research/Science  6 upvotes 1 month ago
      Crushing spironolactone pills and combining them with minoxidil for topical application may be effective for hair loss, with the addition of finasteride suggested. Adding rosemary and peppermint oils can help mask the unpleasant smell.

      community Does the effect of spironolactone on androgenetic alopecia really weaken over time?

      in Female  4 upvotes 4 months ago
      Spironolactone can remain effective for a long time in treating androgenetic alopecia, but it may not completely stop hair loss. Hair loss treatments like spironolactone, finasteride, and dutasteride slow down hair loss rather than cure it, and their effectiveness can vary based on individual response and the aggressiveness of the condition.

      community Spironolactone VS dutasteride for female pattern hair loss

      in Treatment  7 upvotes 9 months ago
      Spironolactone is more potent and lowers testosterone and DHT, while dutasteride only impacts DHT. For female hair loss, checking hormones and considering treatments like oral minoxidil, spironolactone, or topical minoxidil is recommended.

    Related Research

    1 / 1 results